HR 9077 · To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Referred to the House Committee on Energy and Commerce.
- Introduced
- May 29, 2026
- Latest action
- May 29, 2026
- Sponsor
- Rep. Hillary J. Scholten [D-MI-3]
- Policy area
- Unassigned
- Cosponsors
- 0
Recent actions
- May 29, 2026 Referred to the House Committee on Energy and Commerce.
- May 29, 2026 Introduced in House
- May 29, 2026 Introduced in House
Votes
No recorded votes are available for this bill.